In colon cancer, gastroesophageal cancer, and small bowel cancer, the current recommendations support the use of MMR‐IHC and MSI detection through PCR rather than the use of MSI‐NGS for the detection of DNA MMR deficiency due to cost‐effectiveness and diagnostic effectiveness [63, 64]. The gene discussed is MRC1; the disease is mismatch repair cancer syndrome 1.